市场调查报告书
商品编码
1371934
2030 年麻醉设备市场预测:按类型、用途、最终用户和地区分類的全球分析Anesthesia Equipment Market Forecasts to 2030 - Global Analysis By Type, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球麻醉器材市场规模为 83 亿美元,预计 2030 年将达到 147.7 亿美元,预测期内年复合成长率为 8.6%。
一套被称为麻醉设备的特定医疗工具和仪器用于在手术和其他医疗程序期间提供和监测麻醉。它是安全、准确地向患者给药气体或註射等麻醉剂、使患者失去知觉、缓解疼痛、放鬆肌肉的重要设备。麻醉设备一般由调节麻醉剂浓度、流量的装置及监测氧浓度、血压、心率等生命指标的装置结构。
据世界卫生组织称,癌症是全球第一大死亡原因,预计 2020 年将导致 1,000 万人死亡。
现代麻醉技术确保精确和处方麻醉剂给药,确保最佳给药并减少用药错误的机会。此外,药物输送技术的改进,例如患者自控镇痛装置和靶控输液泵,可以根据每个患者的需求进行客製化麻醉剂给药。因此,这些方面正在推动市场规模的扩大。
该设备价格昂贵,因为开发和製造先进的麻醉设备需要在研究、材料和技术方面进行大量投资,而这些成本通常会转嫁给医疗保健提供者。此外,预算限制可能会阻止医疗机构和临床医生投资最新技术,特别是在资源有限的环境中,从而阻碍市场成长。
麻醉设备发展带来的技术进步将进一步改善患者照护。透过人工智慧 (AI) 和机器学习 (ML) 演算法的整合实现资料分析、决策支援和预测建模,帮助麻醉师做出更明智的选择、更有效地提供麻醉并改善患者护理,有助于改善结果。此外,用于麻醉的设备是专门为适应各种手术和患者群体而量身定制的。这使我们能够灵活地适应各种麻醉治疗,包括镇静、局部麻醉和全身麻醉。
市场竞争非常激烈,国内外卖家众多。另一方面,中小企业的产品有限,资金和技术能力也有限。因此,许多供应商在品质、可靠性和研发方面都落后于知名供应商。因此,这些要素预计将在预测期内抑制市场扩张。
COVID-19大流行的疫情对全球经济和医疗保健系统产生了重大影响。在大流行初期,由于 COVID-19 病例不断增加,世界各地的医疗机构停止了择期手术。此外,大流行导致许多人避免去医院,延误了手术并严重扰乱了患者对慢性病的监测和治疗。因此,麻醉设备市场、製造和供应链必须应对产品需求不相容以及向最终消费者按时交付设备等挑战。
由于一次性物品对于保持医疗机构的清洁和减少感染传播至关重要,因此麻醉一次性用品领域预计将占据最大的市场份额。例如喉罩、呼吸管路、气管插管和过滤器。此外,由于它是一次性使用,因此交叉污染的风险较小,并且不需要灭菌。因此,病人安全和感染控制变得越来越重要,麻醉设备市场的这一领域正在稳步扩大。
预计心臟病学领域在预测期内年复合成长率最高。心臟麻醉涉及心臟手术和干预期间麻醉的实施和监测。该领域的设备包括先进的心臟功能监测工具,例如食道心动图 (TEE) 探头、心抟出量监视器和心电图 (ECG)。此外,这些设备对于麻醉师在具有挑战性的心血管手术期间确保患者安全和准确的麻醉管理至关重要。因此,为了改善心臟病学和心血管医学领域的患者治疗效果和安全性,心臟病领域正在解决与心臟手术相关的特殊要求和困难。
由于受益于北美强大的医疗基础设施、最先进的医疗设施和大规模手术,北美在预测期内占据了最大的市场占有率。此外,现代麻醉系统的采用是由法规遵循和严格的安全要求所推动的。人口高龄化和医疗成本上升进一步加速了北美对优质麻醉设备的持续需求。该市场云集了众多知名麻醉设备供应商,创新变得愈加重要。因此,这些方面都有助于市场的扩大。
由于对医疗保健基础设施、严格的法规标准和先进麻醉解决方案的需求不断增长,预计欧洲在预测期内将呈现最高的年复合成长率。欧洲是全球麻醉设备市场中重要且竞争的地区,因为许多欧洲医疗保健系统优先考虑品质和效率。因此,对监护设备和输送系统等尖端麻醉设备的需求不断增加。
According to Stratistics MRC, the Global Anesthesia Equipment Market is accounted for $8.30 billion in 2023 and is expected to reach $14.77 billion by 2030 growing at a CAGR of 8.6% during the forecast period. A specific set of medical tools and instruments known as anesthesia equipment is used to deliver and monitor anesthesia during surgical procedures and other medical treatments. These crucial devices that ensure the safe and accurate administration of anesthetic agents, such as gases and injectable drugs, to patients in order to cause unconsciousness, relieve pain, and relax their muscles. In general, anesthesia equipment consists of devices that regulate the concentration and flow of anesthetic chemicals as well as monitors for vital indicators including oxygen levels, blood pressure, and heart rate.
According to the WHO, cancer is the leading cause of death globally and was responsible for an estimated 10 million deaths in 2020.
Modern anesthetic technology allows for accurate and regulated anesthesia drug administration, ensuring optimal dosage and lowering the possibility of medication errors, this result in increased patient comfort and quicker healing times. Additionally, improvements in drug delivery technologies, such as patient-controlled analgesia devices and target-controlled infusion pumps, enable customized anesthetic delivery that is specialized to the needs of each patient. Therefore, these aspects propel the market size.
Advanced anesthetic equipment development and manufacturing demand large investments in research, materials, and technology, the equipment is expensive since these costs are frequently transferred to healthcare providers. Furthermore, budget restrictions may prevent healthcare facilities and clinicians, particularly in environments with limited resources, from making investments in modern technology which hampers the growth of the market.
The advancements in technology brought forth by the ongoing development of anesthetic equipment further enhance patient care. Data analysis, decision support, and predictive modelling are made possible through the integration of artificial intelligence (AI) and machine learning (ML) algorithms, this helps anaesthesiologists make wise choices, deliver anesthesia more effectively, and enhance patient outcomes. Moreover, the equipment used in anesthesia is made to accommodate a variety of operations and patient groups. Thus, it provides flexibility in terms of various anesthetic treatments, such as sedation, regional anesthesia, and general anesthesia.
The market is competitive since there are many local, national, and international sellers. On the other hand, small and medium-sized suppliers have limited financial and technical capabilities in addition to limited product offerings. As a result, in terms of quality, dependability, and R&D, many providers fall short of well-known vendors. Therefore, during the projection period, these factors will restrain market expansion.
The development of the COVID-19 pandemic had a significant effect on the world economy and healthcare system. Early on in the pandemic, healthcare facilities all across the world stopped performing elective procedures because of the rising number of COVID-19 cases. Moreover, due to the pandemic, many people avoided going to hospitals, procedures were delayed, and patient monitoring and chronic illness treatment were severely disrupted. Therefore, the market for anesthetic equipment, the manufacturing and supply chain had to deal with challenges such as incompatible product demand and on-time delivery of devices to end consumers.
The anesthesia disposables segment is estimated to hold the largest share, due to the disposable items which are essential for preserving cleanliness and limiting the spread of infections in medical facilities. Laryngeal masks, breathing circuits, endotracheal tubes, and filters are just a few examples. Moreover, due to their one-time-use design, they pose less of a danger of cross-contamination and don't require sterilization. Therefore, with a growing emphasis on patient safety and infection control, this sector of the anesthetic equipment market is expanding steadily.
The cardiology segment is anticipated to have highest CAGR during the forecast period. Cardiac anesthesia entails the delivery and supervision of anesthesia during heart procedures and interventions. This segment's equipment includes sophisticated heart function monitoring tools like transesophageal echocardiography (TEE) probes, cardiac output monitors, and electrocardiograms (ECGs). Additionally, for anaesthesiologists to guarantee patient security and accurate anesthetic management during challenging cardiac procedures, these instruments are essential. Therefore, in order to improve patient outcomes and safety in the fields of cardiology and cardiovascular medicine, the cardiology sector addresses the special requirements and difficulties connected with cardiac procedures.
North America commanded the largest market share during the extrapolated period owing to the benefits from a strong healthcare infrastructure, cutting-edge medical facilities, and a significant volume of operations across North America. Additionally, the adoption of contemporary anesthetic systems is driven by regulatory compliance and adherence to exacting safety requirements. The constant need for outstanding anesthetic equipment in North America is further fuelled by an aging population and rising healthcare costs. A significant number of well-known suppliers of anesthetic equipment are present in the market, and technical innovation is becoming increasingly important. Therefore, these aspects contribute to the market's expansion.
Europe is expected to witness highest CAGR over the projection period, owing to healthcare infrastructure, stringent regulatory standards, and a rising demand for advanced anesthesia solutions. Europe is a key and competitive region in the worldwide anesthetic equipment market because many European healthcare systems prioritize quality and efficiency. Therefore, this has led to a consistent demand for cutting-edge anaesthetic equipment, including monitoring devices and delivery systems.
Some of the key players in the Anesthesia Equipment Market include: Ambu A/S, B. Braun Melsungen AG, Becton Dickinson and Company, Dragerwerk AG & Co. KGaA, GE HealthCare Technologies, Inc., Getinge AB, Heyer Medical AG, Koninklijke Philips N.V., Medline Industries, Inc., Medtronic PLC, Penlon Ltd., Pentax, SunMed, LLC, Teleflex Incorporated and Ventlab.
In September 2023, Mayo Clinic and GE HealthCare announce a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.
In July 2023, The American Society of Anesthesiologists (ASA) announced it has been selected as a 2023 Best and Brightest Companies to Work For in the Nation. This marks the seventh consecutive year the Society has received the designation.
In April 2022, GE Healthcare announced the FDA pre-market approval (PMA) for its End-tidal (Et) Control software for general anesthesia delivery on its Aisys CS2.
Table Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.